Mammographic breast density in women with premature ovarian failure: a prospective analysis
- PMID: 24518154
- DOI: 10.1097/GME.0000000000000204
Mammographic breast density in women with premature ovarian failure: a prospective analysis
Abstract
Objective: This study aims to compare breast density between two mammograms in women with premature ovarian failure (POF).
Methods: A cohort study evaluated 56 women with POF. Two mammograms performed at least 2 years apart were analyzed. Mammogram films were digitalized, and images were assessed using a computer-assisted method; the percentage of breast image that is radiologically dense is referred to as the percentage of mammographic density (PMD). Age at menarche, age at onset of POF, length of POF, length of estrogen-progestin therapy (EPT), body mass index (BMI), pregnancy, and age at the time of each mammogram were evaluated.
Results: The mean (SD) age at POF diagnosis was 32.35 (5.95) years. In the first mammogram, the mean (SD) age, BMI, and length of POF were 37.58 (3.72) years, 26.79 (4.86) kg/m, and 5.25 (4.61) years, respectively. EPT had been used for a mean (SD) of 2.71 (3.12) years. In the second mammogram, the mean (SD) age, BMI, and length of POF were 43.23 (4.98) years, 27.6 (5.39) kg/m, and 10.5 (5.11) years, respectively. EPT had been used for a mean (SD) of 7.25 (4.6) years. The mean (SD) interval between mammograms was 5.25 (3) years, and the mean (SD) PMD decreased from 27.78% (21.04%) to 17.53% (15.71%) (P = 0.007). Comparing PMD between women taking EPT and those not taking EPT, we observed no significant differences. In both instances, multiparous women had lower PMD than nulliparous women (P < 0.05). BMI, length of POF, and pregnancy were negatively correlated with PMD.
Conclusions: Breast density in young women with POF decreases across a period of 5 years, regardless of EPT use. Further studies may elucidate how this result will correlate with decision-making in clinical therapeutics and breast cancer risk in POF.
Comment in
-
Mammographic breast density: from Wolfe and beyond.Menopause. 2014 Sep;21(9):920-1. doi: 10.1097/GME.0000000000000308. Menopause. 2014. PMID: 25072956 No abstract available.
Similar articles
-
Determinants of percent mammographic density in women with premature ovarian insufficiency.Climacteric. 2017 Jun;20(3):280-284. doi: 10.1080/13697137.2017.1310836. Epub 2017 Apr 9. Climacteric. 2017. PMID: 28391726
-
Breast density in women with premature ovarian failure using hormone therapy.Gynecol Endocrinol. 2008 Jan;24(1):40-3. doi: 10.1080/09637480701690543. Gynecol Endocrinol. 2008. PMID: 18224543
-
Mammographic densities during the menopausal transition: a longitudinal study of Australian-born women.Menopause. 2007 Mar-Apr;14(2):208-15. doi: 10.1097/01.gme.0000232278.82218.1f. Menopause. 2007. PMID: 17091098
-
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279. J Natl Cancer Inst. 2005. PMID: 16174858 Clinical Trial.
-
[Premature ovarian failure syndrome].Ceska Gynekol. 2000 Mar;65(2):98-102. Ceska Gynekol. 2000. PMID: 10953480 Review. Czech.
Cited by
-
[Successful pregnancy following intracytoplasmic sperm injection?embryo transfer in a patient with premature ovarian insufficiency: a case report].Nan Fang Yi Ke Da Xue Xue Bao. 2017 Oct 20;37(10):1418-1422. doi: 10.3969/j.issn.1673-4254.2017.10.24. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 29070478 Free PMC article. Chinese.
-
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.J Natl Cancer Inst. 2015 Nov 5;108(2):djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26546117 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical